Preliminary evaluation of the potential of 99mTc carbonyl-DTPA-Rituximab as a tracer for sentinel lymph node detection.
暂无分享,去创建一个
[1] S. Subramanian,et al. An indigenous single-vial kit formulation of human serum albumin nanocolloid for use in sentinel lymph node detection. , 2015, Nuclear medicine communications.
[2] J. Correia,et al. Comparative biological evaluation of two [99mTc(CO)3]-dextran pyrazolyl mannose conjugates developed for use in sentinel lymph node detection. , 2014, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[3] G. Samuel,et al. ⁹⁹mTc carbonyl DTPA-rituximab: preparation and preliminary bioevaluation. , 2014, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[4] R. Elashoff,et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. , 2014, The New England journal of medicine.
[5] Yuntao Xie,et al. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy. , 2013, Breast.
[6] J. Correia,et al. Mannosylated dextran derivatives labeled with fac-[M(CO)₃]+ (M = (99m)Tc, Re) for specific targeting of sentinel lymph node. , 2011, Molecular pharmaceutics.
[7] K. Lewandowski,et al. Primary breast lymphoma – a review of the literature and report of three cases , 2011, Archives of medical science : AMS.
[8] J. Correia,et al. New 99mTc(CO)3 mannosylated dextrans bearing S-derivatized cysteine chelator , 2010 .
[9] T. Poli,et al. Sentinel Node Biopsy in Head and Neck Squamous Cell Cancer: 5-Year Follow-Up of a European Multicenter Trial , 2010, Annals of Surgical Oncology.
[10] A. Luini,et al. Sentinel Lymph Node Biopsy in Breast Cancer: Ten-Year Results of a Randomized Controlled Study , 2010, Annals of surgery.
[11] W. Jennings,et al. Primary Breast Lymphoma: The Role of Mastectomy and the Importance of Lymph Node Status , 2007, Annals of surgery.
[12] G. Paintaud,et al. Pharmacokinetics of rituximab and its clinical use: thought for the best use? , 2007, Critical reviews in oncology/hematology.
[13] Dong Soo Lee,et al. Development of 99mTc-neomannosyl human serum albumin (99mTc-MSA) as a novel receptor binding agent for sentinel lymph node imaging , 2004, Nuclear medicine communications.
[14] M. Brechbiel,et al. Development of a spectroscopic assay for bifunctional ligand-protein conjugates based on copper. , 2004, Nuclear medicine and biology.
[15] C K Hoh,et al. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] R. Schibli,et al. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules. , 2000, Bioconjugate chemistry.
[17] G. S. Mijnhout,et al. Radiopharmaceuticals in sentinel lymph-node detection – an overview , 1999, European Journal of Nuclear Medicine.
[18] Roger Schibli,et al. A Novel Organometallic Aqua Complex of Technetium for the Labeling of Biomolecules: Synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]- in Aqueous Solution and Its Reaction with a Bifunctional Ligand , 1998 .
[19] S. Nofech-Mozes,et al. Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard? , 2010, Gynecologic oncology.
[20] D. Eshima,et al. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. , 2000, Seminars in nuclear medicine.
[21] D. Morton,et al. The concept of sentinel node localization: how it started. , 2000, Seminars in nuclear medicine.